Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

Kaufman Bella; Shapira-Frommer Ronnie; Schmutzler Rita K.; Audeh M. William; Friedlander Michael; Balmana Judith; Mitchell Gillian; Fried Georgeta; Stemmer Salomon M.; Hubert Ayala; Rosengarten Ora; Steiner Mariana; Loman Niklas; Bowen Karin; Fielding Anitra; Domchek Susan M.

首页> 外文期刊>Journal of Clinical Oncology >Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

【24h】

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

机译：Olaparib单药治疗晚期癌症和生殖细胞BRCA1 / 2突变的患者

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2015年第3期|共7页
作者
Kaufman Bella; Shapira-Frommer Ronnie; Schmutzler Rita K.; Audeh M. William; Friedlander Michael; Balmana Judith; Mitchell Gillian; Fried Georgeta; Stemmer Salomon M.; Hubert Ayala; Rosengarten Ora; Steiner Mariana; Loman Niklas; Bowen Karin; Fielding Anitra; Domchek Susan M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety [J] . Matulonis U. A., Penson R. T., Domchek S. M., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第6期

机译：Olaparib单药治疗晚期复发性卵巢癌和生殖系BRCA1 / 2突变的患者：疗效和安全性的多研究分析
2. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation [J] . Kaufman Bella, Shapira-Frommer Ronnie, Schmutzler Rita K., Journal of Clinical Oncology . 2015,第3期

机译：Olaparib单药治疗晚期癌症和生殖细胞BRCA1 / 2突变的患者
3. Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy [J] . Domchek Susan M., Aghajanian Carol, Shapira-Frommer Ronnie, Gynecologic Oncology: An International Journal . 2016,第2期

机译：奥拉帕尼单药治疗晚期卵巢癌种系BRCA1 / 2突变携带者和三株或以上现有疗法的疗效和安全性
4. Identification of potential long non-coding RNA biomarkers for breast cancer patients with somatic BRCA1 mutations from RNA-Seq datasets [C] . Jia-Hua Cai, Yu-Ching Chen, Hsueh-Ting Chu, IEEE International Conference on Bioinformatics and Bioengineering . 2018

机译：鉴定来自RNA-SEQ数据集的乳腺癌患者乳腺癌患者的潜在长期非编码RNA生物标志物
5. Dolo?anje Mutacij v Genih BRCA1/2 Iz citolo?kega Materiala Pri Raku jaj?nikov, Jajcevodov in Primarnem Peritonealnem Seroznem Karcinomu =BRCA1/2 mutation testing from cytological samples in patients with ovarian, tubal and primary peritoneal serous cancer [D] . Gornjec, Andreja. 2020

机译：从自我癌症中确定基因Krca1 / 2中的突变吗？
6. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation [O] . Bella Kaufman, Ronnie Shapira-Frommer, Rita K. Schmutzler, -1

机译：Olaparib单药治疗晚期癌症和生殖细胞BRCA1 / 2突变的患者
7. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation [O] . Bella Kaufman, Ronnie Shapira-Frommer, Rita K. Schmutzler, 2015

机译：Olaparib患者晚期癌症和种系BRCA1 / 2突变的单一疗法

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

摘要

著录项

相似文献

相关主题

期刊订阅